Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
| ▸ | HTR6 | P50406 | 5/20 | 0.50 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | CA2 | P00918 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA3 | P07451 | 1/20 | 0.46 |
| ▸ | CA4 | P22748 | 1/20 | 0.46 |
| ▸ | CA6 | P23280 | 1/20 | 0.46 |
| ▸ | CA5A | P35218 | 1/20 | 0.46 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.46 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluoride SCHEMBL775526 | 0.97 | ALDH1A1 (0.58) | ALDH1A1HTR6PSIP1ALOX15L3MBTL1 | |
| SCHEMBL2702059 | 0.86 | ALDH1A1 (0.57) | ALDH1A1CA1CA2CA12CA9 | |
| SCHEMBL16469554 | 0.85 | HTR6 (0.46) | ALDH1A1HTR6PSIP1ALOX15L3MBTL1 | |
| SCHEMBL6544675 | 0.84 | HTR6 (0.50) | ALDH1A1HTR6PSIP1CA1CA2 | |
| SCHEMBL384939 | 0.84 | HTR6 (0.50) | ALDH1A1HTR6PSIP1CA1CA2 | |
| SCHEMBL19033894 | 0.82 | HTR6 (0.48) | ALDH1A1HTR6PSIP1CA1CA2 | |
| SCHEMBL7296391 | 0.81 | PSIP1 (0.46) | ALDH1A1HTR6PSIP1ALOX15CA1 | |
| SCHEMBL9412343 | 0.81 | HTR6 (0.42) | ALDH1A1HTR6PSIP1ALOX15CA1 | |
| SCHEMBL12895710 | 0.81 | SOS1 (0.58) | ALDH1A1CA1CA2CA9TSHR | |
| SCHEMBL2705476 | 0.81 | PTGES2 (0.46) | ALDH1A1HTR6ALOX15CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 267 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113707933-A | Preparation method of solid electrolyte nano dispersion liquid of lithium ion battery and solid electrolyte nano dispersion liquid | 北京卫蓝新能源科技有限公司 | 2021-11-26 | — | — | CN | claimed |
| US-6495336-B1 | OLIGOPEPTIDE DERIVATIVES WHOSE C-TERMINAL AMINO ACID IS ARGININE WHICH IS LINKED TO THE REMAINDER OF AN ELECTROACTIVE ANILINE OR AMINOQUINILONE; SUBSTRATE FOR QUANTITATIVELY DETERMINING ENZYMES, ESPECIALLY THROMBIN, IN BLOOD | PENTAPHARM AG (CH) | 2002-12-17 | — | — | US | claimed |
| US-20250188046-A1 | ULTRAFAST FLOW SYNTHESIS OF FUNCTIONALIZED SULFONYL FLUORIDES AND SUBSEQUENT SUFEX CONNECTIONS VIA LITHIATED CHEMISTRY | POSTECH Research and Business Development Foundation (KR) | 2025-06-12 | — | — | US | disclosed |
| US-12100809-B2 | Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-09-24 | — | — | US | disclosed |
| US-12016896-B2 | Dipeptidomimetics as inhibitors of human immunoproteasomes | CORNELL UNIVERSITY (US) | 2024-06-25 | — | — | US | disclosed |
| US-12016896-B2 | Dipeptidomimetics as inhibitors of human immunoproteasomes | CORNELL UNIVERSITY (US) | 2024-06-25 | — | — | US | disclosed |
| US-20230286997-A1 | Compounds for the Treatment of Cancer and Inflammatory Disease | SHY Therapeutics LLC | 2023-09-14 | — | — | US | disclosed |
| US-20230278958-A1 | TRICYCLIC HETEROCYCLES | MERCK PATENT GMBH (DE) | 2023-09-07 | — | — | US | disclosed |
| US-11724998-B2 | PXR agonists and uses thereof for gut barrier dysfunction treatment and prevention | ALBERT EINSTEIN COLLEGE OF MEDICINE (US) | 2023-08-15 | — | — | US | disclosed |
| US-20230212195-A1 | COMPOUNDS, CONJUGATES, AND COMPOSITIONS OF EPIPOLYTHIODIKETOPIPERAZINES AND POLYTHIODIKETOPIPERAZINES AND USES THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-07-06 | — | — | US | disclosed |
| US-20230174538-A1 | Tricyclic heterocycles | MERCK PATENT GMBH (DE) | 2023-06-08 | — | — | US | disclosed |
| US-20050239994-A1 | Liquid crystal poly(phenylene sulfonic acids) | CASE WESTERN RESERVE UNIVERSITY | 2005-10-27 | — | — | US | disclosed |
| EP-1329160-A2 | 4-ACYLAMINOPYRAZOLE DERIVATIVES | Sankyo Company, Limited (JP) | 2003-07-23 | — | — | EP | disclosed |
| US-6495336-B1 | OLIGOPEPTIDE DERIVATIVES WHOSE C-TERMINAL AMINO ACID IS ARGININE WHICH IS LINKED TO THE REMAINDER OF AN ELECTROACTIVE ANILINE OR AMINOQUINILONE; SUBSTRATE FOR QUANTITATIVELY DETERMINING ENZYMES, ESPECIALLY THROMBIN, IN BLOOD | PENTAPHARM AG (CH) | 2002-12-17 | — | — | US | disclosed |
| EP-1157029-A1 | OLIGOPEPTIDE DERIVATIVES FOR THE ELECTROCHEMICAL MEASUREMENT OF PROTEASE ACTIVITY | Pentapharm AG (CH) | 2001-11-28 | — | — | EP | disclosed |
| WO-2000050446-A1 | OLIGOPEPTIDE DERIVATIVES FOR THE ELECTROCHEMICAL MEASUREMENT OF PROTEASE ACTIVITY | PENTAPHARM AG (CH) | 2000-08-31 | — | — | WO | disclosed |
| EP-0409412-B1 | Diaryl ether cyclic ethers | ICI PLC (GB) | 1994-07-20 | — | — | EP | disclosed |
| EP-0409412-A2 | Diaryl ether cyclic ethers | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1991-01-23 | — | — | EP | disclosed |
| US-4166866-A | Immunosuppressive method with dithiocarbamates | THE CALIFORNIA POLYTECHNIC STATE UNIVERSITY FOUNDATION (US) | 1979-09-04 | — | — | US | disclosed |
| US-4130578-A | Immunosuppressive dithiocarbanilates | THE UPJOHN COMPANY (US) | 1978-12-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230212195-A1 | COMPOUNDS, CONJUGATES, AND COMPOSITIONS OF EPIPOLYTHIODIKETOPIPERAZINES AND POLYTHIODIKETOPIPERAZINES AND USES THEREOF | DNPEP, DHPS, NPEPPS | ALDH1A1 2862/4885HTR6 1438/4885PSIP1 950/4885 |
| US-20250188046-A1 | ULTRAFAST FLOW SYNTHESIS OF FUNCTIONALIZED SULFONYL FLUORIDES AND SUBSEQUENT SUFEX CONNECTIONS VIA LITHIATED CHEMISTRY | FGFR4, STS, FGFR1 | ALDH1A1 1626/4885HTR6 3280/4885PSIP1 196/4885 |
| US-20230278958-A1 | TRICYCLIC HETEROCYCLES | YAP1, TERF2IP, TEAD1 | ALDH1A1 3813/4885HTR6 4554/4885PSIP1 2985/4885 |
| US-20230286997-A1 | Compounds for the Treatment of Cancer and Inflammatory Disease | MAPK6, MAP3K6, MAPK4 | ALDH1A1 2765/4885HTR6 3456/4885PSIP1 3389/4885 |
| US-20230174538-A1 | Tricyclic heterocycles | YAP1, TEAD1, TERF2IP | ALDH1A1 3857/4885HTR6 4497/4885PSIP1 2941/4885 |
| US-11724998-B2 | PXR agonists and uses thereof for gut barrier dysfunction treatment and prevention | NR1H2, NR1H4, NR1H3 | ALDH1A1 3347/4885HTR6 1008/4885PSIP1 2859/4885 |
| US-12016896-B2 | Dipeptidomimetics as inhibitors of human immunoproteasomes | PREP, CTSC, DNPEP | ALDH1A1 3234/4885HTR6 2494/4885PSIP1 2136/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.